Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.7K Sell
13,804
-31,978
-70% -$26.6K ﹤0.01% 12749
2025
Q4
$34.9K Buy
45,782
+26,220
+134% +$43.2K ﹤0.01% 12169
2025
Q3
$37.4K Buy
+19,562
New +$35K ﹤0.01% 12321
2023
Q2
Sell
-31,252
Closed -$57.5K 14765
2023
Q1
$57.5K Sell
31,252
-15,325
-33% -$30.9K ﹤0.01% 11979
2022
Q4
$96.9K Buy
+46,577
New +$93.1K ﹤0.01% 11264

Other funds holding IMRN

Citadel Advisors's IMRN Position: Q1 2026 in Review

Citadel Advisors reduced its Immuron (IMRN) stake by 70% in Q1 2026, selling an estimated $26.6K and leaving 13,804 shares worth $10.7K. The position accounts for ﹤0.01% of the portfolio, ranked #12749.

Citadel Advisors first reported a position in IMRN in Q4 2022 and has held it in 5 quarters since. The position peaked at $96.9K in Q4 2022. 7 funds tracked by Wall St. Rank hold IMRN as of Q1 2026.

  • Citadel Advisors held 13,804 shares of Immuron worth $10.7K as of Q1 2026.
  • Citadel Advisors sold 31,978 Immuron shares in Q1 2026, an estimated $26.6K.
  • Immuron made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #12749 holding.
  • Citadel Advisors first reported a position in Immuron in Q4 2022 and has held it in 5 quarters since.
  • Citadel Advisors's Immuron position peaked at $96.9K in Q4 2022.
  • 7 funds tracked by Wall St. Rank held Immuron as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.